New eye drop targets common eyelid infection
NCT ID NCT07400965
Summary
This study is testing a new medication called GLK-321 for people with Demodex blepharitis, a common eyelid condition caused by tiny mites. About 250 participants will be randomly assigned to receive either the active treatment or a placebo eye drop for 6 weeks. The main goal is to see if GLK-321 safely and effectively clears the crusty debris (collarettes) from the eyelashes that is a key sign of this condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMODEX BLEPHARITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Glaukos Clinical Study Site
RECRUITINGNewport Beach, California, 92663, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.